...
首页> 外文期刊>Endocrine Research >A novel double mutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism.
【24h】

A novel double mutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism.

机译:家族性Leydig细胞发育不全和男性假性雌雄同体的黄体生成素受体中的新型双突变。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report a novel mutant of the luteinizing hormone receptor (LHR) in a case of familial Leydig cell hypoplasia and pseudohermaphrotidism. The proband was homozygous for two missense mutations, T1121C and C1175T, causing substitutions I374T and T3921. The molecular effects of the mutations were investigated by heterologous expression of the WT LHR, the double mutant LHR, or receptors with either the I374T or the T392I mutation, and measuring hormone binding and cAMP signaling. All mutant LHRs exhibited severe defects, including loss of ligand binding and cAMP production. Immunoblots showed little difference in protein levels between the WT and mutant receptors.
机译:我们报告家族性Leydig细胞发育不全和假性雌性激素的情况下,促黄体生成激素受体(LHR)的新型突变。该先证者对于两个错义突变T1121C和C1175T是纯合的,引起了取代I374T和T3921。通过WT LHR,双重突变LHR或具有I374T或T392I突变的受体的异源表达,并测量激素结合和cAMP信号传导,研究了突变的分子效应。所有突变的LHRs都表现出严重的缺陷,包括配体结合的丧失和cAMP产生。免疫印迹显示野生型和突变型受体之间的蛋白质水平差异不大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号